Who owns PIERIS PHARMACEUTICALS INC?
- Ticker: PIRS
- CUSIP Number: 720795202
Tip: Access positions for across all investors
Analyze quarterly positions in Pieris Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pieris Pharmaceuticals stock
Who bought or sold PIERIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 258k | $4.3M | 0% | Sep 2024 |
|
| BML Capital Management | 42k | $699k | 100% | Sep 2024 |
|
| Lynx1 Capital Management | 37k | $621k | -14% | Sep 2024 |
|
| Renaissance Technologies | 32k | $533k | 180% | Sep 2024 |
|
| CM Management | 23k | $373k | 100% | Sep 2024 |
|
| Frazier Life Sciences Management | 16k | $267k | 100% | Sep 2024 |
|
| BlackRock | 13k | $127k | 100% | Jun 2024 |
|
| BlackRock | 13k | $214k | 100% | Sep 2024 |
|
| Geode Capital Management | 12k | $201k | 13% | Sep 2024 |
|
| Citadel Advisors | 12k | $196k | 100% | Sep 2024 |
|
| Vanguard Group | 11k | $111k | 100% | Jun 2024 |
|
| Acadian Asset Management | 3.0k | $49k | -72% | Sep 2024 |
|
| Citigroup | 1.1k | $19k | 0% | Sep 2024 |
|
| Tower Research Capital | 334.00 | $3.3k | 100% | Jun 2024 |
|
| Group One Trading | 312.00 | $5.2k | -3% | Sep 2024 |
|
| Us Bancorp | 138.00 | $2.3k | -13% | Sep 2024 |
|
| Morgan Stanley | 82.00 | $804.895600 | 100% | Jun 2024 |
|
| Barclays | 63.00 | $999.999000 | 0% | Sep 2024 |
|
| Wells Fargo & Company | 60.00 | $994.998000 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 26.00 | $435.216600 | -4% | Sep 2024 |
|
| Bank of America Corporation | 13.00 | $215.091500 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 7.00 | $115.999800 | 100% | Sep 2024 |
|
| Hanson McClain Advisors | 5.00 | $83.000000 | 0% | Sep 2024 |
|